House AA,Anand I,Bellomo R,Cruz D,Bobek I,Anker SD .2010 .Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant, 25(5) : 1416-20.
Bargshaw SM,Cruz DM,Aspromonte N,Daliento L,Ronco F,Sheinfeld G .2010 .Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant, 25(5) : 1406-16.
Dar O,Cowie MR .2008 .Acute heart failure in the intensive care unit: epidemiology. Crit Care Med, 36(1) : S3-8.
Aronson D. .2012 .Cardiorenal syndrome in acute decompensated heart failure. Expert Rev Cardiovasc Ther, 10(2) : 177-89.
Blair JE,Pang PS,Schrier RW,Metra M,Traver B,Cook T .2011 .Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J, 32(20) : 2563-72.
Zahoor S,Arshad MS,Riaz A,Farhan M. .2017 .Precipitants of acute decompensated heart failure and their correlation with the severity of decompensation in a resource poor country. J Islamabad Med Dent Coll, 6(4) : 219-23.
DeFrances CJ,Lucas CA,Buie VC,Golosinskiy A. .2008 .national hospital discharge survey. Natl Health Stat Report, 5 : 1-20.
Zaidi M,Rehman AJ,Haque A,Akhtar S,Maheshwar PK .2014 .Frequency of cardiorenal syndrome type-I in hospitalized children with acute heart failure in a tertiary-care hospital. J Coll Physicians Surg Pak, 24(8) : 577-80.
Naqvi R. Thrombotic .2024 .Microangiopathy and acute kidney injury with malaria: One-year experience at SIUT. Pak J Kidney Dis, 8(2) : 23-6.
Usman MS,Khan MS,Butler J. .2021 .The interplay between diabetes, cardiovascular disease, and kidney disease. In: Chronic Kidney Disease and Type 2 Diabetes, : .
Ronco C,McCullough P,Anker SD,Anand I,Aspromonte N,Bagshaw SM .2010 .Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J, 31(6) : 703-11.
Ronco C .2017 .Cardiorenal syndrome in western countries: epidemiology, diagnosis and management approaches. Kidney Dis, 2(4) : 151-63.
Zarbock A,Küllmar M,Ostermann M,Lucchese G,Baig K,Cennamo A .2021 .Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: The PrevAKImulticenter randomized controlled trial. Anesth Analg, 133(2) : 292-302.
Syed M. .2023 .Hyponatremia in acute decompensated heart failure as a predictor of acute cardiorenal syndrome Type-1. Indian J Cardiovasc Dis Women, 8(2) : 121-5.
Maisons V,Halimi JM,Fauchier G,de Fréminville JB,Goin N,Gueguen J .2023 .Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study. Diabetes Metab, 49(3) : 101441.
Prothasis M,Varma A,Gaidhane S,Kumar S,Khatib N,Zahiruddin QS .2020 .Prevalence, types, risk factors, and outcomes of cardiorenal syndrome in a rural population of central India: A cross-sectional study. J Family Med Prim Care, 9(8) : 4127-33.
Liu M,Li XC,Lu L,Cao Y,Sun RR,Chen S .2014 .Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci, 18(19) : 2918-26.
Kumar A,Shandil R,Gupta D,Ganju N,Shandil A,Shandil A. .2023 .Clinical profile and outcome of patients with cardiorenal syndrome type 1: a cross sectional observational study. Eur J Cardiovasc Med, 13(4) : 258.
Nakayama M. .2013 .Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective. Perit Dial Int, 33(1) : 8-14.
Gigante A,Liberatori M,Gasperini ML,Sardo L,Di Mario F,Dorelli B .2014 .Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward. Cardiorenal Med, 4(2) : 88-94.
Pimienta González R,Couto Comba P,Rodríguez Esteban M,Alemán Sánchez JJ,Hernández Afonso J,Rodríguez Pérez MD .2016 .Incidence, mortality and positive predictive value of type 1 cardiorenal syndrome in acute coronary syndrome. PLoS One, 11(12) : e0167166.
Dreznik Y,Hoffman A,Hamburger T,Ben-Yaacov A,Dux Y,Jacoby H .2018 .Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies. Surgeon, 16(5) : 278-82.